2014

In Baltimore, home of Centers for Medicare and Medicaid Services (CMS), we awoke to a dusting of additional snow. We also woke…

Recently, The Pennsylvania Supreme Court ruled that pharmaceutical companies can be held liable for negligence in the design and…

The National Institutes of Health (NIH) announced a partnership with ten drug makers, as well as eight non-profit organizations,…

Last September, we were the first to report on trends relating to changes in leadership at the FDA's Office of Regulatory Affairs.…

While the pharmaceutical industry scrambles to gather spend data for the Physician Payments Sunshine Act, one issue in particular…

Recently at the CBI Pharmaceutical Compliance Congress a group of State, DOJ and US Attorneys thoroughly reviewed the life cycle…

U.S. Attorney for the District of Massachusetts, Carmen Ortiz, emphasized the importance of compliance programs early on during…

Recently the U.S. Department of Health & Human Services Office of Inspector General issued a report on its "key focus areas"…

The U.S. Department of Justice (DOJ) recently announced a $40.1 million final settlement agreement with CareFusion Corp. to…

At the recent CBI Pharmaceutical Compliance Congress, U.S. Attorney for the District of New Jersey, Paul Fishman, discussed…